Influence of both a static magnetic field and penetratin on magnetic nanoparticle delivery into fibroblasts

Nanomedicine

Volumn 6, Issue 10, 2011, Pages 1719-1731

  Dejardin, Theophile ^a   De La Fuente, Jesus ^b   Del Pino, Pablo ^b   Furlani, Edward P ^c   Mullin, Margaret ^a   Smith, C A ^a   Berry, Catherine C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Laboratory of Glyconanotechnology   (Spain)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

cell uptake; endocytosis; magnetic; magnetic field; nanoparticle n penetratin

Indexed keywords

NANOPARTICLE; PENETRATIN;

ARTICLE; CELL CULTURE; CELL LINE; CELL PERMEABILIZATION; ENDOCYTOSIS; FIBROBLAST; FORCE; HUMAN; HUMAN CELL; MAGNETIC FIELD; PRIORITY JOURNAL; STATIC MAGNETIC FIELD;

CARRIER PROTEINS; CAVEOLINS; CELLS, CULTURED; CLATHRIN; ENDOCYTOSIS; FERRIC COMPOUNDS; FIBROBLASTS; HUMANS; MAGNETIC FIELDS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON; PARTICLE SIZE;

EID: 82455181592     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.65     Document Type: Article

References (57)

1. Borm PJ, Robbins D, Haubold S et al.: The potential risks of nanoparticles: a review carried out for ECEToc. Part Fibre Toxicol. 3, 11 (2006).
2. Xie J, Lee S, Chen X: Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev. 62, 1064-1079 (2010).
3. Sumer B, Gao J: Theranostic nanomedicine for cancer. Nanomedicine 3, 137-140 (2008). (Pubitemid 351611851)
4. Chawla P, Chawla V, Maheshwari R, Saraf SA, Saraf SK: Fullerenes: from carbon to nanomedicine. Mini Rev. Med. Chem. 10, 662-677 (2010).
5. Sithatharam B, Wilson LJ: Gadofullerenes and gadonanotubes: a new paradigm for high performance magnetic resonance imaging contrast agent probes. J. Biomed. Nanotech. 3, 342-352 (2007). (Pubitemid 351877137)
6. Sahoo SK, Labhasetwar: Nanotech approaches to drug delivery and imaging. Drug Discov. Today 8, 1112-1120 (2003). (Pubitemid 37547917)
7. Berry CC: Functionalisation of magnetic nanoparticles for applications in biomedicine: review update. J. Phys. D 42, 224003-224012 (2009).
8. Ohgushi M, Nagayama K, Wada A: Dextran-magnetite: a new relaxation agent and its application to T2 measurements in gel systems. J. Magn. Reson. 29, 599-601 (1978).
9. Berry CC: Possible exploitation of magnetic nanoparticle-cell interaction for biomedical applications. J. Mater. Chem. 15, 543-547 (2005). (Pubitemid 40260739)
10. Berry C, Curtis ASG: Functionalisation of magnetic nanoparticles for applications in biomedicine. J. Phys. D 36, R198-R206 (2003).
11. Soenen SJ, Himmelreich U, Nuytten N, De Cuyper M: Cytotoxic effects of iron oxide nanopartiles and implications for safety in cell labelling. Biomaterials 32, 195-205 (2011).
12. Soenen SJ, Cuyper M: Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplifed with cationic magnetoliposomes. Contrast Media Mol. Imaging 4, 207-219 (2009).
13. McCarthy JR, Weissleder R: Multifuncional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Deliv. Rev. 60, 1241-1251 (2008).
14. Au K W, Liao SY, Lee YK et al.: Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells. Biochem. Biophys. Res. Commun. 379, 898-903 (2009).
15. Haim H, Steiner I, Planet A: Synchronised infection of cell cultures by magnetically controlled virus. J. Virol. 79, 622-625 (2005). (Pubitemid 39648417)
16. Scherer F, Anton M. Schillinger U: Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9, 102-109 (2002). (Pubitemid 34189525)
17. Kamau SW, Hassa PO, Steinz B: Enhancement of the effcacy of non-viral gene delivery by application of a magnetic feld. Nuc. Acids Res. 34, e40 (2006).
18. Lubbe AS, Alexiou C, Bergmann C: Clinical applications of magnetic drug targeting. J. Surg. Res. 95, 200-206 (2001). (Pubitemid 34953556)
19. Frasca G, Gazeau F, Wilhelm C: Formation of a three-dimentional multicellular assembly using magnetic patterning. Langmuir 25, 2348-2354 (2009).
20. Gould P: Nanoparticles probe biosystems. Mat. Today 36, 43 (2004).
21. Mousavi SA, Malerod L, Berg T, Kjeken R: Clathrin-dependent endocytosis. Biochem. J. 377, 1-16 (2004). (Pubitemid 38114427)
22. Zhou L, Chemg R, Tao H et al.: Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release and biodistribution in tumour-bearing mice. Biomacromolecules 2(5), 1460-1467 (2011).
23. Hruby M, Konák C, Ulbrich K: Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J. Control. Release 103, 137-148 (2005). (Pubitemid 40248568)
24. Howl J, Nicholl ID, Jones S: The many futures for cell penetrating peptides: how soon is now? Biochem. Soc. Trans. 35, 767-769 (2007). (Pubitemid 47310364)
25. Letoha T, Keller-Pinter A, Kusz E et al.: Cell-penetrating peptide exploited syndecans. Biochim. Biophys. Acta 1798, 2258-2265 (2010).
26. Frankel AD, Pabo CO: Cellular uptake of tat protein from human immunodefciency virus. Cell 55, 1189-1193 (1988). (Pubitemid 19020071)
27. Green M, Loewenstein PM: Autonomous functional domains of chemically synthesised human immunodefciency virus tat trans-activator protein. Cell 55, 1179-1188 (1988). (Pubitemid 19020070)
28. Berry CC: Intracellular delivery of nanoparticles via the HIV-1 tat peptide. Nanomedicine 3, 357-365 (2008). (Pubitemid 351827312)
29. Berry CC, de la Fuente J, Mullin M, Wai Ling Chu S, Curtis A: Nuclear localisation of HIV-1 tat functionalised gold nanoparticles. IEEE TNB 6, 262-269 (2007). (Pubitemid 350210543)
30. Josephson L, Tung CH, Moore A, Weissledher R: High-effciency intracellular magnetic labelling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 10, 186-191 (1999). (Pubitemid 29147720)
31. Thoren PE, Persson D, Karlsson M, Norden B: The Antennapedia peptide penetratin translocated across lipid bilayers. FEBS Lett. 482, 265-268 (2000).
32. Derossi D, Joliot AH, Chassaing G, Prochiantz A: The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444-10450 (1994). (Pubitemid 24198241)
33. Amand HL, Fant K, Norden B, Esbjorner EK: Stimulated endocytosis in penetratin uptake: effect of arginine and lysine. Biochem. Biophys. Res. Commun. 371, 621-625 (2008).
34. Furlani EP: Analysis of particle transport in a magnetophoretic microsystem. J. Appl. Phys. 99, 024912 (2006).
35. Furlani EP, Ng KC: Analytical model of magnetic nanoparticle transport and capture in the microvasculature. Phys. Rev. E 73, 061919 (2006).
36. Furlani EP, Ng KC: Nanoscale magnetic biotransport with application to magnetofection. Phys. Rev. E 77, 061914 (2008).
37. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A: Cell internalization of the third helix of the antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271, 18188-18193 (1996). (Pubitemid 26250811)
38. Suzuki T, Futaki S, Niwa M, Tanaka S, Ueda K, Sugiura Y: Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277, 2437-2443 (2002). (Pubitemid 34953265)
39. Futaki S, Suzuki T, Ohashi W et al.: Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-5840 (2001).
40. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB: The design, synthesis and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl Acad. Sci. USA 97, 13003-13008 (2000).
41. Richard JP, Melikov K, Vives E et al.: Cell-penetrating peptides. A re-evaluation on the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590 (2003). (Pubitemid 36043612)
42. Lundberg M, Johansson M: Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem. Biophys. Res. Commun. 291, 367-371 (2002). (Pubitemid 34694414)
43. Persson D, Thoren PEG, Esbjorner EK, Goksor M. Lincon P, Norden B: Vesicle size-dependent translocation of penetratin analogs across lipid membranes. Biochim. Biophys. Acta 1665, 142-155 (2004). (Pubitemid 39303579)
44. Duchardt F, Fotin-Mleczek M, Schwarz H, Fischer R, Brock R: A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffc 8, 848-866 (2007). (Pubitemid 46971632)
45. Ludin P, Johansson H, Guterstam P et al.: Distinct uptake routes of cell-penetrating peptide conjugates. Bioconjug Chem. 19, 2535-2542 (2008).
46. Lindsay MA: Peptide-mediated cell delivery: application in protein target validation. Curr. Opin. Pharmacol. 2, 587-594 (2002).
47. Fischer PM, Krausz E, Lane DP: Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of medicating membrane translocation. Bioconjug. Chem. 12, 825-841 (2001). (Pubitemid 33136850)
48. Kelf TA, Sreenivasan VKA, Sun J, Kim EJ, Goldys EM, Zvyagin AV: Non-specifc uptake of surface-functionalised quantum dots. Nanotechnology 21, 285105-285112 (2010).
49. Loubery S, Wilhelm C, Hurbain I, Neveu S, Lauvard D, Coudrier E: Different microtubule motors move early and late endocytic compartments. Traffc 9, 492-509 (2008). (Pubitemid 351351611)
50. Nan X, Sims P, Chen P, Xie XS: Observation of individual microtubule motor steps in living cells with endocytosed quantum dots. J. Phys. Chem. B 109, 24220-24224 (2005). (Pubitemid 43063664)
51. Smith CA, de la Fuente J, Pelaz B, Furlani EP, Mullin M, Berry CC: The effect of static magnetic felds and tat peptides on cellular and nuclear uptake of magnetic nanoparticles. Biomaterials 15, 4392-4400 (2010).
52. Moisescu MG, Leveque P, Verjus M-A, Kovacs E, Mir LM: 900 Mhz modulated electromagnetic felds accelerate the clathrin-mediated endocytosis pathway. Bioelectromagnetics 30, 222-230 (2009).
53. Myjhaylyk O, Zelphati O, Rosenecker J, Plank C: Recent advances in magnetofectin and its potential to deliver siRNAs in vitro. Methods Mol. Biol. 487, 111-146 (2009).
54. Myjhaylyk O, Zelphati O, Rosenecker J, Plank C: siRNA delivery by magnetofection. Curr. Opin. Mol. Ther. 10, 493-505 (2008).
55. Cho SK, Kim JH, Riu KZ, Cho SG, Park SP: Simple, effcient and reproducible gene transfection of mouse embryonic stem cells by magnetofection. Stem Cells Dev. 17, 133-141 (2008). (Pubitemid 351271607)
56. Buerli T, Pellegrino C, Laer K et al.: Effcient transfection of DNA or shRNA vectors into neurons using magnetofection. Nat. Protoc. 2, 3090-3101 (2007).
57. Sauer AM, Bruin KG, Ruthardt N, Mykhaylyk O, Planc C, Brauchle C: Dynamics of magnetic lipoplexes studied by single particle tracking in living cells. J. Control. Release 137, 136-145 (2009).